作者
Barbara Mühlemann, Samuel H Wilks, Lauren Baracco, Meriem Bekliz, Juan Manuel Carreño, Victor M Corman, Meredith E Davis-Gardner, Wanwisa Dejnirattisai, Michael S Diamond, Daniel C Douek, Christian Drosten, Isabella Eckerle, Venkata-Viswanadh Edara, Madison Ellis, Ron AM Fouchier, Matthew Frieman, Sucheta Godbole, Bart Haagmans, Peter J Halfmann, Amy R Henry, Terry C Jones, Leah C Katzelnick, Yoshihiro Kawaoka, Janine Kimpel, Florian Krammer, Lilin Lai, Chang Liu, Sabrina Lusvarghi, Benjamin Meyer, Juthathip Mongkolsapaya, David C Montefiori, Anna Mykytyn, Antonia Netzl, Simon Pollett, Annika Rössler, Gavin R Screaton, Xiaoying Shen, Alex Sigal, Viviana Simon, Rahul Subramanian, Piyada Supasa, Mehul S Suthar, Sina Türeli, Wei Wang, Carol D Weiss, Derek J Smith
发表日期
2024/5/15
期刊
Science Translational Medicine
卷号
16
期号
747
页码范围
eadl1722
出版商
American Association for the Advancement of Science
简介
The evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) requires ongoing monitoring to judge the ability of newly arising variants to escape the immune response. A surveillance system necessitates an understanding of differences in neutralization titers measured in different assays and using human and animal serum samples. We compared 18 datasets generated using human, hamster, and mouse serum and six different neutralization assays. Datasets using animal model serum samples showed higher titer magnitudes than datasets using human serum samples in this comparison. Fold change in neutralization of variants compared to ancestral SARS-CoV-2, immunodominance patterns, and antigenic maps were similar among serum samples and assays. Most assays yielded consistent results, except for differences in fold change in cytopathic effect assays. Hamster serum samples …
引用总数